PureTech Health (NASDAQ:PRTC) Upgraded at Leerink Partnrs

Leerink Partnrs upgraded shares of PureTech Health (NASDAQ:PRTCFree Report) to a strong-buy rating in a research report released on Monday morning, Zacks.com reports. Leerink Partnrs also issued estimates for PureTech Health’s FY2024 earnings at ($4.27) EPS, FY2025 earnings at ($4.84) EPS and FY2026 earnings at ($3.77) EPS.

Separately, Leerink Partners started coverage on PureTech Health in a research report on Monday. They set an outperform rating and a $45.00 price objective on the stock.

Read Our Latest Stock Analysis on PRTC

PureTech Health Stock Up 0.5 %

PureTech Health stock opened at $19.89 on Monday. The stock’s 50 day simple moving average is $22.26 and its two-hundred day simple moving average is $25.68. PureTech Health has a fifty-two week low of $17.08 and a fifty-two week high of $34.00.

Institutional Trading of PureTech Health

A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. acquired a new stake in PureTech Health plc (NASDAQ:PRTCFree Report) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by hedge funds and other institutional investors.

PureTech Health Company Profile

(Get Free Report)

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.

See Also

Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.